First-generation versus second-generation long-acting injectable antipsychotic drugs and time to relapse.

We found no evidence of advantage in terms of maintaining response in SGA LAI versus FGA LAI. Prescriber choice should be guided by other factors such as side-effect profile, patient acceptability and price.